Tag Archives: BioNTech AG

Health-sector IPO action heating up big time after Labor Day pause.

Health-sector initial public offerings are alive and kicking again, as over $1B was raised last week among just for aspiring players, now taking their chances in the big league stock… Read more »

BioNTech raises $325M in Series B round, skipping IPO for now

The News: Germany’s BioNTech raises eye-popping €290M ($325M) in Series B round to fund personalized mRNA cancer vaccines, eschewing IPO for now. Just where does German biotech stand vis-à-vis the… Read more »